NCT07390292Not yet recruiting
Assessment of Cognitive Function and Functional Performance in Patients With Type 2 Diabetes
The Effect of Cognitive Functions on Functional Capacity, Balance, Fear of Falling and Quality of Life in Patients With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 5 Feb 2026
Brief summary (registry, in English)
Diabetes is a chronic metabolic disease that is becoming a growing public health problem worldwide, affecting people's lives in many ways. It is characterized by impaired carbohydrate, lipid, and protein metabolism associated with insufficient insulin secretion and/or reduced sensitivity to the metabolic effects of insulin.Along with diabetes, many complications may develop in affected individuals. Cognitive impairments are now also considered an important and common complication of diabetes.The aim of this study is to investigate the effects of cognitive function levels on functional capacity, balance, fear of falling, and quality of life in individuals with type 2 diabetes.In this context, participants' cognitive function levels will be assessed using the Mini-Mental State Examination and the Stroop Test. Functional capacity will be evaluated using the 6-Minute Walk Test. Balance performance will be assessed using the Biodex Balance System and the Four Square Step Test. Lower extremity muscle strength will be measured using a digital hand-held dynamometer and the 30-Second Sit-to-Stand Test. Fear of falling will be evaluated using the Falls Efficacy Scale-International (FES-I), the Functional Reach Test, and the Timed Up and Go (TUG) Test. Participants' quality of life will be assessed using the WHOQOL-BREF quality of life questionnaire.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 80 (estimated)
- First submitted
- 5 Jan 2026
- Start date
- Feb 2026
- Primary completion date
- Apr 2026
- Lead sponsor
- Bezmialem Vakif University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07390292
What you commit to
- Study type: Observational
- Planned participants: 80
- From Feb 2026 to the primary completion date, Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having a diagnosis of any neurological or psychiatric disorder (e.g., hemiplegia, Alzheimer's disease, Parkinson's disease)
- Having uncontrolled hypertension and/or uncontrolled cardiac arrhythmia
- Having vertigo or other vestibular system disorders
- Having major musculoskeletal disorders
- Having undergone percutaneous transluminal coronary angioplasty or having a cardiac pacemaker
Other
- Being pregnant
- Being unable to read or write in Turkish
Who the study is looking for
- Being between 40 and 65 years of age
- Having an HbA1c level between 6.5 and 11
- Having been diagnosed with diabetes for at least 1 year
- Scoring 24 or higher on the Mini-Mental State Examination
- Being able to walk independently without assistance
- Having provided voluntary participation and signed written informed consent
Age in the registry: 40 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bezmialem Vakif University Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.